---
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Concepts#label
  :object: LY246708
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#changeDescription
  :object: ''
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#creationDate
  :object: '2016-01-01T00:00:00+00:00'
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#explanatoryComment
  :object: ''
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#hasIdentifier
  :object: http://www.transceleratebiopharmainc.com/LY246708/V1#PR_SI
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#hasState
  :object: http://www.transceleratebiopharmainc.com/LY246708/V1#PR_RS
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#lastChangeDate
  :object: '2020-04-15T19:19:39+02:00'
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/ISO11179Types#origin
  :object: ''
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#acronym
  :object: H2Q-MC-LZZT
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#forIndication
  :object: http://www.transceleratebiopharmainc.com/IND_ALZ/V1#IND
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#interventionModel
  :object: http://www.transceleratebiopharmainc.com/CPT_TALib-ALZ-BWE_V003/V1#PR_TUC1
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#masking
  :object: http://www.transceleratebiopharmainc.com/CPT_TALib-ALZ-BWE_V003/V1#PR_TUC2
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#shortTitle
  :object: ''
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#specifiesArm
  :object: http://www.assero.co.uk/ARM#0ac1d245034a693e8162cd5411f641e2c5d8c13f
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#specifiesArm
  :object: http://www.assero.co.uk/ARM#19bf56b95c95a7ff1f6bff8f07c06c906e75022e
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#specifiesArm
  :object: http://www.assero.co.uk/ARM#277ca11c0868821a747951dad75cadc2ec72a550
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#specifiesEpoch
  :object: http://www.assero.co.uk/EP#23c859f4f777dc72aa029df6686fccf5faec11cf
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#specifiesEpoch
  :object: http://www.assero.co.uk/EP#50783a7176132d9652b0dc8ce197ed67a97a896b
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#studyPhase
  :object: http://www.transceleratebiopharmainc.com/LY246708/V1#PR_TUC3
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#studyType
  :object: http://www.transceleratebiopharmainc.com/LY246708/V1#PR_TUC4
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.assero.co.uk/Protocol#title
  :object: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS)
    in Patients with Mild to Moderate Alzheimerâ€™s Disease.
- :subject: http://www.transceleratebiopharmainc.com/LY246708/V1#PR
  :predicate: http://www.w3.org/1999/02/22-rdf-syntax-ns#type
  :object: http://www.assero.co.uk/Protocol#Protocol
